Article
Plasma cholesteryl ester transfer protein concentrations predict cardiovascular events in patients with coronary artery disease treated with pravastatin.
Journal of internal medicine - 1 Aug 2006
Marschang P, Sandhofer A, Ritsch A, Fiŝer I, Kvas E, Patsch J R
Abstract excerpt
OBJECTIVE: The B1B1 variant of the cholesteryl ester transfer protein (CETP) TaqIB polymorphism and high plasma CETP concentrations are associated with favourable angiographic outcomes in pravastatin-treated patients suffering from coronary artery disease (CAD). The purpose of the present study was to test whether CETP TaqIB genotypes and/or plasma CETP concentrations at baseline also predict clinical end-points...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
